A clinical trial of the vaccine against COVID-19 found it induces an immune reaction.
Trials involving 1,077 healthy adults between April 23 and May 21 showed the injection led to them making antibodies and white blood cells that can fight COVID-19. It did not produce any serious side effects.
Professor Sarah Gilbert, from the University of Oxford, UK, said: “There is still much work to be done before we can confirm if our vaccine will help manage the COVID-19 pandemic, but these early results hold promise. “As well as continuing to test our vaccine in phase-three trials, we need to learn more about the virus — for example, we still do not know how strong an immune response we need to provoke to effectively protect against Sars-Cov-2 infection.
“If our vaccine is effective, it is a promising option as these types of vaccine can be manufactured at large scale. “A successful vaccine against Sars-Cov-2 could be used to prevent infection, disease and death in the whole population, with high-risk populations such as hospital workers and older adults prioritized to receive vaccination.”
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Promising Sign As Coronavirus Vaccine Developed By AstraZeneca And Oxford University Appears Safe, Early Trials ShowThe vaccine is still in early-stage clinical trials, and it is yet to be seen whether it can protect people against the virus.
Read more »
Coronavirus vaccine from Oxford and AstraZeneca shows positive response in early trialA potential coronavirus vaccine developed by Oxford University in the U.K. has produced an immune response in an early-stage human trial, according to newly released data published Monday in medical journal The Lancet.
Read more »
Oxford coronavirus vaccine generates promising Phase 1/2 results: Study
Read more »
Oxford coronavirus vaccine generates promising Phase 1/2 results: StudyA team of scientists at the University of Oxford released promising results showing their COVID-19 vaccine appears safe in an early-stage study — welcome news for one of the most advanced vaccine programs in the world. The Phase 1/2 results, published Monday in the scientific journal The Lancet, also
Read more »
University of Oxford vaccine is safe and induces early immune reaction, early results suggestThe coronavirus pandemic has brought countries to a standstill. In many places, as countries reopen, Covid-19 cases are on the rise. Follow here for the latest.
Read more »
Oxford vaccine trial shows ‘double immunity’ against COVID-19Oxford University released the results of its phase 1 trial, and found the vaccine creates double immunity antibody cells. They are now ready to move forward with more aggressive testing, including clinical trials in the United States.
Read more »